CLINICAL_TRIALS
ClinicalTrials.gov record update
Partially Blinded Study to Assess Reactogenicity & Safety of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ in Healthy Infants After a Hepatitis B Birth Dose
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00317187
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:50.393989+00:00
- Published At
- 2018-08-15T00:00:00+00:00
- Record Updated At
- 2018-08-15
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Hepatitis B", "Diphtheria", "Whole Cell Pertussis", "Tetanus", "Haemophilus Influenzae Type b"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-08-15"- protocolSection.identificationModule.nctId
"NCT00317187"- protocolSection.identificationModule.officialTitle
"Partially Blinded Study to Assess Reactogenicity \u0026 Safety of GSK Biologicals\u0027 Tritanrix\u2122-HepB/Hib-MenAC vs Tritanrix\u2122-HepB/Hiberix\u2122 in Healthy Infants After a Hepatitis B Birth Dose"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.